Pharmacovigilance Jobs for B.Pharm/M.Pharm in India – Verified Openings at Syneos Health



✅ Syneos Health Hiring Safety & PV Specialist I – Apply Now (1–3 Yrs, Gurugram)


🏢 Company:
Syneos Health
📍 Location: Gurugram, India
🎓 Eligibility: B.Pharm, M.Pharm, Pharm.D, M.Sc, B.Sc (Life Sciences or related fields)
💰 Salary: As per industry standards
🧪 Experience: 1–3 Years
📝 Job Type: Full-Time | Pharmacovigilance | Drug Safety
🔎 Verified: ✅ Verified Job via Medical Jobs India – hitechplus.in


🌐 About Syneos Health

Syneos Health is a global leader in biopharmaceutical solutions, dedicated to accelerating the success of new therapies. As a trusted name in clinical research and pharmacovigilance, Syneos empowers teams to bring life-changing treatments to patients faster and safer.


📄 Job Overview – Safety & PV Specialist I

  • Enter and manage Individual Case Safety Reports (ICSRs) per SOPs
  • Perform MedDRA coding and create narrative summaries
  • Support literature screening and xEVMPD compliance
  • Ensure global regulatory compliance and data integrity
  • Participate in audits and quality checks


✅ Eligibility & Skills

  • Bachelor’s or Master’s in Pharmacy, Lifesciences, or related field
  • Basic knowledge of ICSR processing, GVP, MedDRA coding
  • Understanding of global PV regulations (GCP, ICH)
  • Detail-oriented, analytical, and excellent communicator
  • Certification in PV/Clinical Research is a plus


🎁 Why Join Syneos Health

  • 🌍 Contribute to 94% of FDA-approved drugs
  • 📈 Global career growth and technical training
  • 🤝 Diverse, inclusive, and supportive culture
  • 💼 Competitive salary and total rewards

📌 Note Before You Apply:
Review responsibilities carefully and tailor your resume with related skills, certifications, or projects.


👇 Application Link Will Be Visible in 15 Seconds 👇



🟢 Verified Job via Medical Jobs India – hitechplus.in

#SyneosHealthJobs #DrugSafety #PharmacovigilanceIndia #ICSRProcessing #LifeScienceCareers #PVSpecialist #ClinicalResearchIndia #MedicalJobsIndia

Post a Comment

0 Comments

×
×
×